[Prognostic Value of <i>CDKN2A</i> Copy Number Deletion in Patients with Diffuse Large B-Cell Lymphoma].
<i>CDKN2A</i> copy number deletion is an independent risk factor for OS in DLBCL, and accurate identification of <i>CDKN2A</i> copy number deletion can predict the prognosis of DLBCL patients.
Authors
- Liang Shao (ORCID: https://orcid.org/0000-0001-6411-3766)
- Wenxin Tian (ORCID: https://orcid.org/0000-0001-6654-6469)
- Wei-Yuan Ma
- Sha Liu (ORCID: https://orcid.org/0000-0002-6710-8126)
- Yan Li (ORCID: https://orcid.org/0000-0003-1208-1226)
Institutions
- Shihezi University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-04-01
- DOI
- https://doi.org/10.19746/j.cnki.issn.1009-2137.2025.02.011
- Primary Topic
- Clinical practice guidelines implementation
- Type
- article